As the use of weight loss medication Ozempic continues to grow, concerns are emerging about its safety profile. According to a recent study, over one in eight US adults have taken the drug, but more than 30% stop taking it after just four weeks due to side effects. The most common issues reported include nausea, diarrhea, and vision problems.
While Ozempic has been shown to have significant health benefits, such as weight loss and improved blood sugar control, its unpleasant side effects are becoming a growing concern for medical professionals. Vision changes, erectile dysfunction, and mood swings are just some of the reported side effects. However, it’s not just these common issues that are worrying doctors – there are also reports of severe medical illnesses, including pancreatitis and musculoskeletal disorders.
A UK regulator has highlighted the potential deadly side effect of acute pancreatitis after at least ten deaths were linked to this condition among British users of GLP-1 drugs. The US Food and Drug Administration (FDA) has also expressed concern over the risk of pancreatitis associated with Ozempic use.
Despite these concerns, many experts believe that the benefits of Ozempic outweigh the risks. When used as prescribed, the medication has been shown to improve the lives of thousands of people with type 2 diabetes. Researchers are also investigating its potential use in treating other conditions, including dementia and substance use disorders.
To better understand the side effects of GLP-1 drugs, more research is needed, particularly on representative populations, including women who are often underrepresented in clinical trials. However, many experts agree that the risks associated with Ozempic should not be enough to prevent its use for those who benefit from it.
Source: https://www.dw.com/en/weight-loss-drugs-linked-with-growing-number-of-side-effects/a-73229511